GWM
ACHC icon

Geneos Wealth Management’s Acadia Healthcare ACHC Stock Holding History

Geneos Wealth Management’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-61
Closed -$1.38K – 2466
2025
Q2 		$1.38K Sell
61
-3
-5% -$71 ﹤0.01% 2901
2025
Q1 		$1.94K Buy
64
+17
+36% +$648 ﹤0.01% 2776
2024
Q4 		$1.86K Sell
47
-92
-66% -$4.15K ﹤0.01% 2618
2024
Q3 		$8.81K Buy
+139
New +$10K ﹤0.01% 1885
2017
Q1 		– Sell
-69
Closed -$2K – 2055
2016
Q4 		$2K Hold
69
– – ﹤0.01% 1818
2016
Q3 		$3K Buy
+69
New +$3.59K ﹤0.01% 1669

Other funds holding ACHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.19B AUM 14.29% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.05B AUM 71.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Geneos Wealth Management's ACHC Position: Q3 2025 in Review

Geneos Wealth Management sold out of Acadia Healthcare (ACHC) in Q3 2025, closing a stake of 61 shares — an estimated $1.38K sold.

Geneos Wealth Management first reported a position in ACHC in Q3 2016 and held it in 6 quarters. The position peaked at $8.81K in Q3 2024. 270 funds tracked by Wall St. Rank hold ACHC as of Q3 2025.

  • Geneos Wealth Management reported no remaining Acadia Healthcare position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 61 Acadia Healthcare shares in Q3 2025, an estimated $1.38K.
  • Geneos Wealth Management first reported a position in Acadia Healthcare in Q3 2016 and held it in 6 quarters.
  • Geneos Wealth Management's Acadia Healthcare position peaked at $8.81K in Q3 2024.
  • 270 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.